Detalhe da pesquisa
1.
Lorlatinib for the treatment of inflammatory myofibroblastic tumour with TPM4-ALK fusion following failure of entrectinib.
Anticancer Drugs
; 31(10): 1106-1110, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32868646
2.
Modification of the Early Gene Enhancer-promoter Improves the Oncolytic Potency of Adenovirus 11.
Mol Ther
; 31(1): 300, 2023 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36476265
3.
Pazopanib, a promising option for the treatment of aggressive fibromatosis.
Anticancer Drugs
; 28(4): 421-426, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28099210
4.
Safety and Efficacy of Modified FOLFIRINOX for Advanced Pancreatic Adenocarcinoma: A UK Single-Centre Experience.
Oncology
; 89(5): 281-7, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26372905
5.
Radiation-induced angiosarcoma of the breast: retrospective analysis at a regional treatment centre.
Breast Cancer
; 31(2): 272-282, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38147173
6.
Modification of the early gene enhancer-promoter improves the oncolytic potency of adenovirus 11.
Mol Ther
; 20(2): 306-16, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22086234
7.
Adjuvant chemotherapy and follow-up for recurrences in localized testicular cancer.
Future Oncol
; 13(11): 947-950, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28481147
8.
PRSS3 promotes tumour growth and metastasis of human pancreatic cancer.
Gut
; 59(11): 1535-44, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20947888
9.
Dose-limiting toxicity and maximum tolerated dose: still fit for purpose?
Lancet Oncol
; 16(13): 1287-8, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26433816
10.
Trastuzumab beyond progression in advanced breast cancer: national guidance versus oncologist's decision.
Oncology
; 86(1): 22-3, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24335099
11.
Improving clinical trial recruitment: experience of a tertiary renal oncology centre.
Oncology
; 85(5): 297-8, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24217289
12.
Biological approaches to therapy of pancreatic cancer.
Pancreatology
; 8(4-5): 431-61, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18724071
13.
Trends in the characteristics, dose-limiting toxicities and efficacy of phase I oncology trials: The Cancer Research UK experience.
Eur J Cancer
; 66: 9-16, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27514008
14.
A Comprehensive Single Institutional Review of 2 Years in a Designated Fast-Track Sarcoma Diagnostic Clinic Linked with a Sarcoma Specialist Advisory Group: Meeting the Target but Failing the Task?
Sarcoma
; 2016: 6032606, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27340367
15.
Novel therapies for pancreatic cancer: setbacks and progress.
Future Oncol
; 6(7): 1061-4, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20624116
16.
Presentation and management of pulmonary artery sarcoma.
Clin Sarcoma Res
; 5(1): 3, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25628857
17.
Tivozanib for the treatment of metastatic renal cancer.
Expert Rev Anticancer Ther
; 13(6): 649-60, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23773100
18.
Desmoplastic small round cell tumour: characteristics and prognostic factors of 41 patients and review of the literature.
Clin Sarcoma Res
; 3(1): 14, 2013 Nov 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-24280007
19.
Prolonged response of relapsed high grade serous ovarian carcinoma to the oral angiokinase inhibitor nintedanib in a patient with a germline BRCA1 mutation.
Gynecol Oncol Case Rep
; 3: 7-10, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-24371652
20.
Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles.
Viruses
; 2(1): 78-106, 2010 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20543907